Symphony Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $476K | Buy |
+2,353
| New | +$476K | 0.06% | 158 |
|
|
2025
Q1 | – | Sell |
-859
| Closed | -$368K | – | 221 |
|
|
2024
Q4 | $368K | Sell |
859
-531
| -38% | -$227K | 0.06% | 158 |
|
|
2024
Q3 | $644K | Sell |
1,390
-811
| -37% | -$376K | 0.11% | 124 |
|
|
2024
Q2 | $1.04M | Sell |
2,201
-135
| -6% | -$63.9K | 0.19% | 90 |
|
|
2024
Q1 | $976K | Buy |
2,336
+1,454
| +165% | +$608K | 0.23% | 84 |
|
|
2023
Q4 | $383K | Sell |
882
-1,480
| -63% | -$643K | 0.08% | 148 |
|
|
2023
Q3 | $821K | Sell |
2,362
-819
| -26% | -$285K | 0.2% | 85 |
|
|
2023
Q2 | $1.11M | Buy |
3,181
+413
| +15% | +$144K | 0.27% | 73 |
|
|
2023
Q1 | $864K | Sell |
2,768
-25
| -0.9% | -$7.81K | 0.22% | 88 |
|
|
2022
Q4 | $805K | Buy |
+2,793
| New | +$805K | 0.21% | 93 |
|
|
2022
Q3 | – | Sell |
-1,700
| Closed | -$477K | – | 202 |
|
|
2022
Q2 | $477K | Sell |
1,700
-630
| -27% | -$177K | 0.14% | 136 |
|
|
2022
Q1 | $643K | Buy |
+2,330
| New | +$643K | 0.15% | 113 |
|
|
2020
Q3 | – | Sell |
-1,000
| Closed | -$290K | – | 159 |
|
|
2020
Q2 | $290K | Buy |
+1,000
| New | +$290K | 0.14% | 109 |
|